| Oct 29 |
Exagen to Announce Third Quarter 2024 Results on November 12, 2024
|
| Oct 21 |
Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence
|
| Sep 13 |
Shareholders in Exagen (NASDAQ:XGN) have lost 84%, as stock drops 12% this past week
|
| Sep 4 |
Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
|
| Aug 9 |
Exagen Inc. (XGN) Soars to 52-Week High, Time to Cash Out?
|
| Aug 5 |
Exagen, Inc. (XGN) Q2 2024 Earnings Call Transcript
|
| Aug 5 |
Exagen GAAP EPS of $0.16 beats by $0.50, revenue of $15.1M beats by $1.97M
|
| Aug 5 |
Exagen Inc. (XGN) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 2 |
Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference
|
| Aug 1 |
Exagen Appoints Jeffrey G. Black as New Chief Financial Officer
|
